This Is Massive News for Eli Lilly Investors
The Motley FoolA panel of advisors to the Food and Drug Administration (FDA) recently recommended Eli Lilly’s Alzheimer’s candidate.
A panel of advisors to the Food and Drug Administration (FDA) recently recommended Eli Lilly’s Alzheimer’s candidate.
